Sol-Gel Technologies Announces Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa.
Dermatology Company Announces Six Exclusive License Agreements
Dermatology Company Announces Six Exclusive…
Dermatology Company Announces Six Exclusive License Agreements
Sol-Gel Technologies Announces Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa.